GLI2 and acute myeloid leukemia: In a previous work, we showed that a high GLI1 and GLI2 expression represents a negative prognostic marker in AML, and that targeted inhibition of GLI1 and GLI2 mediates anti-leukemic effects in vitro and in vivo [7].